# RELAFEN DS

NDC: 15370-170
Generic name: NABUMETONE
Labeler / Manufacturer: Carwin Pharmaceutical Associates, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190920

FDA application: ANDA203166

## Active ingredients

- NABUMETONE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"15370-170"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=15370-170
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9a0af85-6c43-4a2d-ba75-0be4ca64c931